Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
about
The detection, treatment, and biology of epithelial ovarian cancerMesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancerMesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3Recent progress in pancreatic cancerMesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy.Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancerMesothelin targeted cancer immunotherapyCharacterization of human mesothelin transcripts in ovarian and pancreatic cancerStromelysin-1 and mesothelin are differentially regulated by Wnt-5a and Wnt-1 in C57mg mouse mammary epithelial cellsGenetic alteration and gene expression modulation during cancer progressionGenetic abnormalities in pancreatic cancerClinical impacts of mesothelin expression in gastrointestinal carcinomasMolecular therapeutics in pancreas cancerImmunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trialsVaccines for pancreatic cancerCurrent advances in immunotherapy for pancreatic cancerRecognition of Mesothelin by the Therapeutic Antibody MORAb-009: STRUCTURAL AND MECHANISTIC INSIGHTSAdvances in anticancer immunotoxin therapyExploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarraysEstablishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model systemA novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity.New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.Pancreatic cancer.Serum biomarker panels for the detection of pancreatic cancerTargeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.Gene expression patterns in pancreatic tumors, cells and tissues.Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types.Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.Human antibodies for immunotherapy development generated via a human B cell hybridoma technology.Imaging pancreatic cancer using bioconjugated InP quantum dots.Re-adapting T cells for cancer therapy: from mouse models to clinical trials.Mesothelin promotes cell proliferation in the remodeling of neonatal rat pancreas.Discovery of mesothelin and exploiting it as a target for immunotherapy.Mesothelin Immunotherapy for Cancer: Ready for Prime Time?Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy.Targeted therapies for pancreatic cancer.Biological approaches to therapy of pancreatic cancer.Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer.Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panel
P2860
Q21198791-F32D9C92-2A1C-4D81-9214-D25D2DC0159EQ24622837-4C3B55E1-E85F-4D47-81CB-FDB7E090938CQ24622968-C04C80D4-015E-4270-A2FB-72A6CDE2DDF1Q24626346-68555209-DFA1-4BA3-9EF7-3D34E0BE770AQ24642374-6DDD66E0-CB04-49E8-BB68-699907C0A1D8Q24651062-D795EBC7-5636-41FE-99FC-098065742803Q24656242-B7CA26AD-E580-4D88-9974-AA99A244DFC8Q24791193-E8F97486-5334-426D-B299-CA41EBD78B54Q24797540-5282370E-7626-4542-BF84-FB88CD298C6CQ24798750-07EC9193-168E-4D3C-858E-43935784FE56Q24800194-A9AD85DF-AFB2-49D9-83D7-18A2839BD38DQ26748680-07735955-CB86-4871-B33F-15B410DB6286Q26751709-AD8DF093-015B-4D6A-8A54-07D2E9DD35D6Q26781538-8A02543C-D270-467B-BC01-900B4A45558CQ26825850-120D6B1E-E21D-4F6F-A1C2-1D0FAB5DC3CBQ26830170-89542A2E-199A-402D-B636-D505B2CE767DQ27670713-8EDD7543-041C-484C-B67F-58A07F862307Q28085551-963FF945-65C8-460A-8ECC-3EEBAFFEB895Q28185685-E194DE5D-EBFF-4A16-B78B-FDC4C2D1848BQ28485145-D4F0CBB7-A53F-4D13-AC05-612925CCACD7Q30478956-488DDE93-A878-4DE0-AA34-335FFB2CC46FQ30489770-B11B33B8-7F2D-4396-BB68-388FC8B0ED92Q30490247-461E6E30-B085-464B-90A0-19DD58DCD61DQ30499531-826372BB-D63C-4050-B487-5A50221F2BD8Q30539569-32FB2999-A02E-4C53-AD83-1C004E92CF26Q30571464-CD21C30E-AC05-4E56-9331-75CDC0AB4AC5Q30830632-55965730-DCC1-4A21-B51E-33E0B8AD9359Q30980266-0759846B-1B96-462B-89A8-A742CD09A04FQ31048088-0B17C832-0612-4DEA-8F87-C1892E3B5EA7Q33234976-47F196A2-9349-4E83-B512-ECF5C593D388Q33412483-5B737B30-92D0-4286-B41C-6C191D6361B4Q33588711-3C8CDA9F-FC74-4CE9-AAB1-DD66D11AB39DQ33735285-1DB9663B-7876-4099-B8A6-FB14D43F6443Q33772688-6BD771DB-21C4-435E-8D5F-0DF76EED0571Q33816551-1F373531-3183-4D6F-B2BA-02879B947997Q33828838-9F10DB1A-2F30-4D15-A6DD-604978356B83Q33899923-33C60D38-8E18-47B7-B40C-E7C6E88BCAC6Q33899938-EB9205A2-2DB8-4E87-8905-774AFF590E66Q33929696-2FDC1CF5-3CEB-48FE-A505-85A8704F34C9Q33957368-7B15BCFA-169B-4D49-9846-02930D1A3D73
P2860
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mesothelin is overexpressed in ...... sis of gene expression (SAGE).
@ast
Mesothelin is overexpressed in ...... sis of gene expression (SAGE).
@en
type
label
Mesothelin is overexpressed in ...... sis of gene expression (SAGE).
@ast
Mesothelin is overexpressed in ...... sis of gene expression (SAGE).
@en
prefLabel
Mesothelin is overexpressed in ...... sis of gene expression (SAGE).
@ast
Mesothelin is overexpressed in ...... sis of gene expression (SAGE).
@en
P2093
P921
P1476
Mesothelin is overexpressed in ...... ysis of gene expression (SAGE)
@en
P2093
C Iacobuzio-Donahue
J L Cameron
R E Wilentz
R H Hruban
P304
P407
P577
2001-12-01T00:00:00Z